AMR Centre, Shionogi team up for superbug therapy - PharmaTimes

AMR Centre, Shionogi team up for superbug therapy  PharmaTimes

The AMR Centre has announced a landmark agreement with the Japanese pharma company Shionogi to take forward its anti-virulence program, COT-143.



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today